Items where authors include "Hoskin, P."

Article

Zhong, J. orcid.org/0000-0001-5325-3739, Davey, A., Frood, R. orcid.org/0000-0003-2681-9922 et al. (13 more authors) (2025) Combining MRI radiomics, hypoxia gene signature score and clinical variables for prediction of biochemical recurrence-free survival after radiotherapy in prostate cancer. La Radiologia Medica, 130. pp. 1139-1148. ISSN 0033-8362

Shortall, J., Osorio, E.V., Green, A. et al. (7 more authors) (2025) The value of post radiotherapy prostate specific antigen dynamics for prostate cancer risk stratification models. Physics and Imaging in Radiation Oncology, 34. 100787. ISSN 2405-6316

Simões, R. orcid.org/0000-0003-3874-3128, Gulliford, S., Seddon, B. et al. (13 more authors) (2024) Predicting radiotherapy response, toxicities and quality-of-life related functional outcomes in soft tissue sarcoma of the extremities (PredicT) using dose–volume constraints development: a study protocol. BMJ Open, 14 (8). e083617. ISSN 2044-6055

Rescigno, P., Porta, N., Finneran, L. et al. (26 more authors) (2024) Capivasertib in combination with enzalutamide for metastatic castration resistant prostate cancer after docetaxel and abiraterone: Results from the randomized phase II RE-AKT trial. European Journal of Cancer, 205. 114103. ISSN 0959-8049

Zhong, J. orcid.org/0000-0001-5325-3739, Kobus, M. orcid.org/0000-0002-1290-0626, Maitre, P. et al. (9 more authors) (2023) MRI-guided Pelvic Radiation Therapy: A Primer for Radiologists. RadioGraphics, 43 (11). ARTN e230052. ISSN 0271-5333

Andratschke, N., Willmann, J., Appelt, A.L. orcid.org/0000-0003-2792-9218 et al. (16 more authors) (2022) European Society for Radio-therapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making. The Lancet Oncology, 23 (10). e469-e478. ISSN 1470-2045

Parker, C.C., James, N.D. orcid.org/0000-0002-7314-8204, Brawley, C.D. orcid.org/0000-0003-3641-278X et al. (43 more authors) (2022) Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial. PLOS Medicine, 19 (6). e1003998. ISSN 1549-1277

Choudhury, A., Porta, N., Hall, E. et al. (9 more authors) (2021) Hypofractionated radiotherapy in locally advanced bladder cancer : an individual patient data meta-analysis of the BC2001 and BCON trials. Lancet Oncology, 22 (2). pp. 246-255. ISSN 1470-2045

Sartor, O., Hoskin, P., Coleman, R.E. orcid.org/0000-0002-4275-1043 et al. (6 more authors) (2016) Chemotherapy following radium-223 dichloride treatment in ALSYMPCA. Prostate, 76 (10). pp. 905-916. ISSN 0270-4137

Burton, C., Linch, D., Hoskin, P. et al. (10 more authors) (2006) A phase III trial comparing CHOP to PMitCEBO with or without G-CSF in patients aged 60 plus with aggressive non-Hodgkin's lymphoma. British Journal of Cancer, 94 (6). pp. 806-813. ISSN 0007-0920

Burton, C., Smith, P., Vaughan-Hudson, G. et al. (5 more authors) (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. British Journal of Haematology, 130 (4). pp. 536-541. ISSN 0007-1048

Conference or Workshop Item

Swinton, M., Portner, R., Brooks, L. et al. (8 more authors) (2023) MR Delta Radiomics during Radiotherapy to Prostate Cancer: Does Dose per Fraction Matter? In: ESTRO 2023, 13-16 May 2023, Vienna, Austria.

Portner, R., McWilliam, A., Zhong, J. et al. (16 more authors) (2022) Prostate Magnetic Resonance Imaging Delta-Radiomics during Image-Guided Conventional Fractionation and Stereotactic Ablative Radiotherapy. In: UNSPECIFIED.

Proceedings Paper

Thiruthaneeswaran, N., Bibby, B.A.S., Pereira, R. et al. (8 more authors) (2020) The radiosensitivity index predicts benefit from HDR brachytherapy in high-risk prostate cancer. In: Radiotherapy & Oncology. ESTRO 2020, 28 Nov - 01 Dec 2020, Online. Elsevier , S1086-S1087.